[Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005947:Glucose / Q000378:metabolism; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D010629:Phenformin; D005947:Glucose; D005905:Glyburide
Influenza di un nuovo prodotto ipoglicemizzante orale (glibenclamide-fenformina) su alcuni aspetti del ricambio lipidico